1. Home
  2. CSPI vs LXEO Comparison

CSPI vs LXEO Comparison

Compare CSPI & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSPI
  • LXEO
  • Stock Information
  • Founded
  • CSPI 1968
  • LXEO 2017
  • Country
  • CSPI United States
  • LXEO United States
  • Employees
  • CSPI N/A
  • LXEO N/A
  • Industry
  • CSPI EDP Services
  • LXEO
  • Sector
  • CSPI Technology
  • LXEO
  • Exchange
  • CSPI Nasdaq
  • LXEO Nasdaq
  • Market Cap
  • CSPI 146.9M
  • LXEO 140.6M
  • IPO Year
  • CSPI 1987
  • LXEO 2023
  • Fundamental
  • Price
  • CSPI $15.62
  • LXEO $2.95
  • Analyst Decision
  • CSPI
  • LXEO Strong Buy
  • Analyst Count
  • CSPI 0
  • LXEO 5
  • Target Price
  • CSPI N/A
  • LXEO $22.80
  • AVG Volume (30 Days)
  • CSPI 30.9K
  • LXEO 819.0K
  • Earning Date
  • CSPI 05-07-2025
  • LXEO 05-08-2025
  • Dividend Yield
  • CSPI 0.77%
  • LXEO N/A
  • EPS Growth
  • CSPI N/A
  • LXEO N/A
  • EPS
  • CSPI 0.02
  • LXEO N/A
  • Revenue
  • CSPI $55,514,000.00
  • LXEO N/A
  • Revenue This Year
  • CSPI N/A
  • LXEO N/A
  • Revenue Next Year
  • CSPI N/A
  • LXEO N/A
  • P/E Ratio
  • CSPI $829.95
  • LXEO N/A
  • Revenue Growth
  • CSPI N/A
  • LXEO N/A
  • 52 Week Low
  • CSPI $10.76
  • LXEO $2.32
  • 52 Week High
  • CSPI $21.95
  • LXEO $19.50
  • Technical
  • Relative Strength Index (RSI)
  • CSPI 44.56
  • LXEO 41.97
  • Support Level
  • CSPI $14.80
  • LXEO $2.90
  • Resistance Level
  • CSPI $17.94
  • LXEO $4.59
  • Average True Range (ATR)
  • CSPI 0.86
  • LXEO 0.52
  • MACD
  • CSPI -0.08
  • LXEO 0.06
  • Stochastic Oscillator
  • CSPI 26.11
  • LXEO 22.41

About CSPI CSP Inc.

CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

Share on Social Networks: